{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:47:21Z","timestamp":1791542841627,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474414"],"award-info":[{"award-number":["82474414"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341235"],"award-info":[{"award-number":["82341235"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.dld.2025.10.011","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T17:08:30Z","timestamp":1761412110000},"page":"2286-2296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effect of T cell-related vaccines on inflammatory bowel disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8291-6212","authenticated-orcid":false,"given":"Ning","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengsheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.dld.2025.10.011_bib0001","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.medj.2021.04.003","article-title":"Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset","volume":"2","author":"Kalimuddin","year":"2021","journal-title":"Med"},{"issue":"7871","key":"10.1016\/j.dld.2025.10.011_bib0002","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-021-03681-2","article-title":"Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans","volume":"596","author":"Alter","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.dld.2025.10.011_bib0003","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/s41467-022-28517-z","article-title":"Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab","volume":"13","author":"Lin","year":"2022","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.dld.2025.10.011_bib0004","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1002\/jmv.28063","article-title":"The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNF\u03b1 blockade","volume":"94","author":"Geisen","year":"2022","journal-title":"J Med Virol"},{"issue":"9","key":"10.1016\/j.dld.2025.10.011_bib0005","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/ecco-jcc\/jjac048","article-title":"Cellular and humoral immune responses to SARS-CoV-2 vaccination in inflammatory bowel disease patients","volume":"16","author":"Cerna","year":"2022","journal-title":"J. Crohns Colitis"},{"issue":"1","key":"10.1016\/j.dld.2025.10.011_bib0006","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/apt.17264","article-title":"Systemic and T cell-associated responses to SARS-CoV-2 immunisation in gut inflammation (STAR SIGN study): effects of biologics on vaccination efficacy of the third dose of mRNA vaccines against SARS-CoV-2","volume":"57","author":"Woelfel","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.dld.2025.10.011_bib0007","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159500","article-title":"Favorable vaccine-induced SARS-CoV-2-specific T cell response profile in patients undergoing immune-modifying therapies","volume":"132","author":"Qui","year":"2022","journal-title":"J Clin Investig"},{"issue":"4","key":"10.1016\/j.dld.2025.10.011_bib0008","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000484","article-title":"Preserved SARS-CoV-2 vaccine cell-mediated immunogenicity in patients with inflammatory bowel disease on immune-modulating therapies","volume":"13","author":"Boland","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"issue":"8","key":"10.1016\/j.dld.2025.10.011_bib0009","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/ibd\/izac193","article-title":"Higher cell-mediated immune responses in patients with inflammatory bowel disease on anti-TNF therapy after COVID-19 vaccination","volume":"29","author":"Caldera","year":"2023","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.dld.2025.10.011_bib0010","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/ibd\/izac071","article-title":"The T-cell response to SARS-CoV-2 vaccination in inflammatory bowel disease is augmented with anti-TNF therapy","volume":"28","author":"Li","year":"2022","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.dld.2025.10.011_bib0011","first-page":"712","article-title":"Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments","volume":"73","author":"Zhang","year":"2024","journal-title":"Gut"},{"issue":"15","key":"10.1016\/j.dld.2025.10.011_bib0012","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.dld.2025.10.011_bib0013","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.dld.2025.10.011_bib0014","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/0145445516673998","article-title":"Intercoder reliability and validity of WebPlotDigitizer in extracting graphed data","volume":"41","author":"Drevon","year":"2016","journal-title":"Behav Modif"},{"issue":"3","key":"10.1016\/j.dld.2025.10.011_bib0015","first-page":"325","article-title":"A modified Newcastle-Ottawa scale for assessment of study quality in genetic urological research","volume":"79","author":"Joseph","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.dld.2025.10.011_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103175","article-title":"mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses","volume":"144","author":"van den Dijssel","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.dld.2025.10.011_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105317","article-title":"T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study","volume":"108","author":"Wolf","year":"2024","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.dld.2025.10.011_bib0018","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/ecco-jcc\/jjad182","article-title":"Antibody responses to influenza vaccination are diminished in patients with inflammatory bowel disease on Infliximab or Tofacitinib","volume":"18","author":"Liu","year":"2024","journal-title":"J Crohns Colitis"},{"issue":"6","key":"10.1016\/j.dld.2025.10.011_bib0019","doi-asserted-by":"crossref","first-page":"S533","DOI":"10.1016\/S0016-5085(23)02235-7","article-title":"High-throughput T-cell receptor sequencing identified strong effect of hla types on T-cell response to Sars-cov-2 vaccine in both ibd and non-ibd individuals","volume":"164","author":"Li","year":"2023","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.dld.2025.10.011_bib0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/vaccines11030591","article-title":"COVID-19 vaccine booster shot preserves T cells immune response based on interferon-gamma release assay in inflammatory bowel disease (IBD) patients on anti-TNFa treatment","volume":"11","author":"Pavia","year":"2023","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.dld.2025.10.011_bib0021","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4049\/jimmunol.2300190","article-title":"Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in adult patients with immune-mediated inflammatory diseases","volume":"211","author":"Cheung","year":"2023","journal-title":"J Immunol"},{"key":"10.1016\/j.dld.2025.10.011_bib0022","doi-asserted-by":"crossref","first-page":"104788","DOI":"10.1016\/j.ebiom.2023.104788","article-title":"Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-a-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formation","volume":"96","author":"Garner-Spitzer","year":"2023","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.dld.2025.10.011_bib0023","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3390\/jpm12050694","article-title":"Impaired humoral immunity with concomitant preserved T cell reactivity in IBD patients on treatment with Infliximab 6 month after vaccination with the SARS-CoV-2 mRNA vaccine BNT162b2: A pilot study","volume":"12","author":"Vollenberg","year":"2022","journal-title":"J Pers Med"},{"issue":"11","key":"10.1016\/j.dld.2025.10.011_bib0024","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159721","article-title":"Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases","volume":"7","author":"Dayam","year":"2022","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.dld.2025.10.011_bib0025","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S2468-1253(22)00274-6","article-title":"COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study","volume":"7","author":"Alexander","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2025.10.011_bib0026","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/vaccines8030455","article-title":"High immunogenicity to influenza vaccination in Crohn\u2019s Disease patients treated with Ustekinumab","volume":"8","author":"Doornekamp","year":"2020","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.dld.2025.10.011_bib0027","first-page":"426","article-title":"T- and B-cell immune responses of patients who had undergone colectomies to oral administration of Salmonella enterica serovar Typhi Ty21a vaccine","volume":"10","author":"Kilhamn","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"8","key":"10.1016\/j.dld.2025.10.011_bib0028","article-title":"Recombinant Herpes zoster vaccine lowers shingles complication risk in patients with inflammatory bowel disease","volume":"19","author":"Yichen","year":"2025","journal-title":"J Crohn\u2019s Colitis"},{"issue":"6","key":"10.1016\/j.dld.2025.10.011_bib0029","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ecco-jcc\/jjae008","article-title":"Recombinant zoster vaccine [RZV] is effective in patients with inflammatory bowel disease: A US propensity matched cohort study","volume":"18","author":"Aakash","year":"2024","journal-title":"J Crohn's Colitis"},{"issue":"8","key":"10.1016\/j.dld.2025.10.011_bib0030","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/all.15247","article-title":"Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination","volume":"77","author":"Hollstein","year":"2022","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.dld.2025.10.011_bib0031","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00002371-200203000-00001","article-title":"Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy","volume":"25","author":"Keilholz","year":"2002","journal-title":"J Immunother"},{"issue":"2","key":"10.1016\/j.dld.2025.10.011_bib0032","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.medj.2021.12.004","article-title":"Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients","volume":"3","author":"Khoo","year":"2022","journal-title":"Med"},{"issue":"7868","key":"10.1016\/j.dld.2025.10.011_bib0033","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","article-title":"BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans","volume":"595","author":"Sahin","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.dld.2025.10.011_bib0034","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MIB.0000000000001013","article-title":"Effects of education and information on vaccination behavior in patients with inflammatory bowel disease","volume":"23","author":"Coenen","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.dld.2025.10.011_bib0035","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.dld.2017.12.027","article-title":"Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: results from a web-based study","volume":"50","author":"Paul","year":"2018","journal-title":"Dig Liver Dis"},{"issue":"8","key":"10.1016\/j.dld.2025.10.011_bib0036","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses","volume":"101","author":"Melmed","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.dld.2025.10.011_bib0037","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/ecco-jcc\/jjv064","article-title":"Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake","volume":"9","author":"Malhi","year":"2015","journal-title":"J Crohn's Colitis"},{"issue":"6","key":"10.1016\/j.dld.2025.10.011_bib0038","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway memory CD4(+) T cells mediate protective immunity against emerging Respiratory coronaviruses","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity,"},{"issue":"4","key":"10.1016\/j.dld.2025.10.011_bib0039","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202187","article-title":"Mapping and role of T cell response in SARS-CoV-2-infected mice","volume":"218","author":"Zhuang","year":"2021","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.dld.2025.10.011_bib0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nm.1929","article-title":"Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10","volume":"15","author":"Sun","year":"2009","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.dld.2025.10.011_bib0041","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/ecco-jcc\/jjab147","article-title":"T cell response after SARS-CoV-2 vaccination in immunocompromised patients with inflammatory bowel disease","volume":"16","author":"Reuken","year":"2022","journal-title":"J Crohns Colitis"},{"issue":"8","key":"10.1016\/j.dld.2025.10.011_bib0042","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses","volume":"101","author":"Melmed","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.dld.2025.10.011_bib0043","first-page":"272","article-title":"Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab","volume":"34","author":"Kaine","year":"2007","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.dld.2025.10.011_bib0044","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/gutjnl-2011-300256","article-title":"Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease","volume":"61","author":"Cullen","year":"2012","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.dld.2025.10.011_bib0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.crohns.2013.08.008","article-title":"Infliximab and\/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease","volume":"8","author":"Hagihara","year":"2014","journal-title":"J Crohn's Colitis"},{"issue":"5","key":"10.1016\/j.dld.2025.10.011_bib0046","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/ibd\/izx101","article-title":"Immunogenicity of quadrivalent influenza vaccine for patients with inflammatory bowel disease undergoing immunosuppressive therapy","volume":"24","author":"Shirai","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.dld.2025.10.011_bib0047","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/gutjnl-2014-307127","article-title":"Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results","volume":"64","author":"Wyant","year":"2014","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.dld.2025.10.011_bib0048","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/ijc.35063","article-title":"Impaired acute-phase humoral immunity is the major factor predicting unfavorable outcomes in multiple myeloma patients with SARS-CoV-2 Omicron variants outbreak infection","volume":"155","author":"Li","year":"2024","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.dld.2025.10.011_bib0049","first-page":"67","article-title":"Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273","volume":"130","author":"Samuel","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.dld.2025.10.011_bib0050","article-title":"IgG anti-RBD levels during 8-month follow-up post-vaccination with BNT162b2 and mRNA-1273 vaccines in healthcare workers: A one-center study","volume":"12","author":"Sergio","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.dld.2025.10.011_bib0051","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s43587-022-00343-4","article-title":"Impaired CD4(+) T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination","volume":"3","author":"Jo","year":"2023","journal-title":"Nat Aging"},{"issue":"6","key":"10.1016\/j.dld.2025.10.011_bib0052","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10522-018-9754-8","article-title":"H. L., the impact of aging on CD4+ T cell responses to influenza infection","volume":"19","author":"Erica","year":"2018","journal-title":"Biogerontology"},{"issue":"2","key":"10.1016\/j.dld.2025.10.011_bib0053","article-title":"Intestinal mucus barrier: A potential therapeutic target for IBD","volume":"24","author":"Yaru","year":"2024","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.dld.2025.10.011_bib0054","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/ecco-jcc\/jjad027","article-title":"Recruitment and residence of intestinal T cells - lessons for therapy in IBD","volume":"17","author":"H","year":"2023","journal-title":"J Crohn's Colitis"},{"issue":"3","key":"10.1016\/j.dld.2025.10.011_bib0055","article-title":"Nonequilibrium antigen recognition during infections and vaccinations","volume":"14","author":"Roberto","year":"2023","journal-title":"Phys Rev X"},{"issue":"7","key":"10.1016\/j.dld.2025.10.011_bib0056","first-page":"1019","article-title":"Antibody responses to SARS-CoV-2 after infection or vaccination in children and young adults with inflammatory bowel disease","volume":"28","author":"Joelynn","year":"2021","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.dld.2025.10.011_bib0057","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3390\/vaccines11091411","article-title":"Humoral immunity in immunosuppressed IBD patients after the third SARS-CoV-2 vaccination: A comparison with healthy control subjects","volume":"11","author":"Vollenberg","year":"2023","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.dld.2025.10.011_bib0058","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s40520-021-01917-9","article-title":"Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease","volume":"33","author":"Calafat","year":"2021","journal-title":"Aging Clin Exp Res"},{"issue":"7","key":"10.1016\/j.dld.2025.10.011_bib0059","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.14309\/ajg.0000000000003541","article-title":"ACG Clinical Guideline update: preventive care in inflammatory bowel disease","volume":"120","author":"Francis","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"10.1016\/j.dld.2025.10.011_bib0060","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2024-334395","article-title":"British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025","volume":"74","author":"Gordon","year":"2025","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.dld.2025.10.011_bib0061","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","article-title":"ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease","volume":"15","author":"Kucharzik","year":"2021","journal-title":"J Crohn's Colitis"},{"issue":"4","key":"10.1016\/j.dld.2025.10.011_bib0062","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine","volume":"23","author":"Chunfeng","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.dld.2025.10.011_bib0063","first-page":"248","article-title":"Sweeten PAMPs: role of sugar complexed PAMPs in innate immunity and vaccine biology","volume":"4","author":"Ranjeet","year":"2013","journal-title":"Front Immunol"},{"issue":"01","key":"10.1016\/j.dld.2025.10.011_bib0064","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4149\/av_2023_110","article-title":"Kinetics of interferon-\u03bb and receptor expression in response to in vitro respiratory viral infection","volume":"67","author":"Alexey","year":"2023","journal-title":"Acta Virol"},{"issue":"6","key":"10.1016\/j.dld.2025.10.011_bib0065","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Bali","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.dld.2025.10.011_bib0066","article-title":"Polio virotherapy provokes MDA5 signaling and CD4+ T cell help to mediate cancer in situ vaccination. Microbiology and molecular biology reviews","volume":"89","author":"Matthias","year":"2025","journal-title":"MMBR"},{"issue":"12","key":"10.1016\/j.dld.2025.10.011_bib0067","article-title":"Lipid nanoparticles as adjuvant of norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9- and type I IFN-dependent pathway","volume":"98","author":"Weiqian","year":"2024","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.dld.2025.10.011_bib0068","first-page":"666","article-title":"Systematic review with network meta-analysis: risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease","volume":"57","author":"Shahida","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.dld.2025.10.011_bib0069","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4049\/jimmunol.1201331","article-title":"Varicella zoster-specific CD4+Foxp3+ T cells accumulate after cutaneous antigen challenge in humans","volume":"190","author":"Milica","year":"2013","journal-title":"J Immunol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582501151X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S159086582501151X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T19:25:08Z","timestamp":1773257108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S159086582501151X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":69,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S159086582501151X"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2025.10.011","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of T cell-related vaccines on inflammatory bowel disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2025.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}